6月10日下午，以“乘势而上·同心致远”为主题的圣元药业2025经销商合作洽谈会隆重启幕。Centering on the core strategy of taurine health products for full-life-cycle population management, the conference witnessed landmark contract signings between Shengyuan Pharmaceutical and distributor representatives from four major regions including Fujian, Guangxi, Chongqing and Sichuan, marking the official launch of an extensive in-depth cooperation network of taurine health products covering key markets nationwide.
Zhu Yuxuan, Chairman of Shengyuan Environmental Protection; Chen Wenyu, Deputy General Manager; Wang Tiejun, Chief Technology Officer; Zhu Zhuowei, Deputy General Manager of Marketing Department; Shi Xuchao, Brand Director; Lin Yanxing, Administrative Director of General Office and other senior executives attended the event. They joined distributors from all across the country to envision the broad prospects of the taurine big health industry.
At the conference, multiple distributor representatives shared their real-world experience with the taurine product line and expressed confidence in the market, demonstrating high recognition of the commercial value of core products including Shengyuan Tree American Ginseng & Taurine Oral Liquid, Vitality Tree Taurine Energy Drink, and Vitality Tree Taurine L-Carnitine Sports Nutrition Beverage.
Speech by Distributor Representative
Chairman Zhu Yuxuan delivered a concluding speech, elaborating thoroughly on the company’s core strategy of intensive development in the taurine health sector as well as its win-win vision.
Chairman Zhu Yuxuan stated that Shengyuan Pharmaceutical has long focused on exploring and applying the core value of taurine in human health throughout all life stages, and is committed to developing scientific, precise, full-range taurine health solutions. Distributor partners are core co-builders of Shengyuan Pharmaceutical’s taurine ecosystem. The company will continue to supply partners with a full lineup of highly market-competitive taurine products spanning "basic nutritional support to functional health intervention". It will comprehensively boost partners’ market development and service capabilities via targeted brand marketing, professional end-market sales empowerment (such as joint initiatives with national wellness campaigns, sports events and community health promotions), as well as flexible regional policies, enabling all partners to share the dividends brought by the vigorous growth of the taurine health industry.
The successful signing with distributors from the four major national regions stands as strong market recognition of Shengyuan Pharmaceutical’s professional expertise in deeply cultivating the taurine sector and developing full-life-cycle health products. The extensive geographical coverage and core channels outlined in the agreements lay a solid network foundation for the company to achieve its annual goal of making premium taurine health products accessible to broader consumer groups. Authoritative statistics indicate that the global taurine application market is expanding at a compound annual growth rate of over 8%. As a major producer of taurine with massive domestic consumption potential, China boasts promising prospects for big-health products centered on taurine. Shengyuan Pharmaceutical’s diversified product portfolio caters to multiple scenarios, including daily wellness (oral liquids, instant energy supply (energy drinks), and professional sports nutrition (sports beverages). By tapping into segmented market tracks, the brand meets consumers’ refined, scenario-specific demands for health goods.
Distributors Sign Contracts On-site
Taking the strategic signing ceremonies as a new starting point, against the backdrop of rising public health awareness and surging demand for precision nutrition, Shengyuan Pharmaceutical is joining hands with distributor partners across the country to build a health service network covering diverse consumption scenarios relying on its full-spectrum lineup of scientific taurine products. The fruitful outcomes of this conference will not only inject strong momentum into Shengyuan Pharmaceutical’s market expansion in the new year, but also further advance the high-quality development of China’s taurine application industry.
